Literature DB >> 19910071

PEG IFN alfa-2a vs. alfa-2b: and the winner is ...?

Antonio Craxì1.   

Abstract

Entities:  

Year:  2009        PMID： 19910071     DOI： 10.1016/j.jhep.2009.10.020

Source DB:  PubMed          Journal:  J Hepatol        ISSN： 0168-8278            Impact factor:   25.083


× No keyword cloud information.
  4 in total

Review 1.  Pegylated interferons alpha2a and alpha2b in the treatment of chronic hepatitis C.

Authors:  Alessio Aghemo; Maria Grazia Rumi; Massimo Colombo
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2010-07-20       Impact factor: 46.802

2.  Inhibition of hepatitis C virus replication by semi-synthetic derivatives of glycopeptide antibiotics.

Authors:  Susan Obeid; Svetlana S Printsevskaya; Eugenia N Olsufyeva; Kai Dallmeier; David Durantel; Fabien Zoulim; Maria N Preobrazhenskaya; Johan Neyts; Jan Paeshuyse
Journal:  J Antimicrob Chemother       Date:  2011-03-24       Impact factor: 5.790

3.  Time-Resolved Effect of Interferon-Alpha 2a on Activities of Nuclear Factor Kappa B, Pregnane X Receptor and on Drug Disposition Genes.

Authors:  Dirk Theile; Lelia Wagner; Cindy Bay; Walter Emil Haefeli; Johanna Weiss
Journal:  Pharmaceutics       Date:  2021-05-28       Impact factor: 6.321

4.  A meta-analysis that compares the use of either peginterferon-α2a or peginterferon-α2b plus ribavirin for HCV infection.

Authors:  Nan Xiao; Shuang Shi; Hui Zhuang
Journal:  Hepat Med       Date:  2010-07-28
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.